Head to Head Analysis: Sycamore Entertainment Group (OTCMKTS:SEGI) & Forte Biosciences (NASDAQ:FBRX)

Sycamore Entertainment Group (OTCMKTS:SEGI) and Forte Biosciences (NASDAQ:FBRX) are both consumer discretionary companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, institutional ownership, risk and profitability.

Institutional & Insider Ownership

77.6% of Forte Biosciences shares are held by institutional investors. 75.5% of Sycamore Entertainment Group shares are held by company insiders. Comparatively, 9.6% of Forte Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility and Risk

Sycamore Entertainment Group has a beta of 49.22, meaning that its share price is 4,822% more volatile than the S&P 500. Comparatively, Forte Biosciences has a beta of 0.04, meaning that its share price is 96% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings for Sycamore Entertainment Group and Forte Biosciences, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sycamore Entertainment Group	0	0	0	0	0.00
Forte Biosciences	0	0	3	0	3.00

Forte Biosciences has a consensus price target of $3.25, suggesting a potential downside of 36.59%. Given Forte Biosciences’ stronger consensus rating and higher possible upside, analysts clearly believe Forte Biosciences is more favorable than Sycamore Entertainment Group.

Profitability

This table compares Sycamore Entertainment Group and Forte Biosciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sycamore Entertainment Group	N/A	N/A	N/A
Forte Biosciences	N/A	-117.85%	-98.67%

Earnings and Valuation

This table compares Sycamore Entertainment Group and Forte Biosciences”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sycamore Entertainment Group	N/A	N/A	N/A	N/A	N/A
Forte Biosciences	N/A	N/A	-$31.48 million	($18.25)	-0.28

About Sycamore Entertainment Group

Sycamore Entertainment Group, Inc., a diversified entertainment company, which specializes in the acquisition, marketing, and worldwide distribution of feature-length motion pictures. The company is based in Seattle, Washington.

About Forte Biosciences

Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc. is headquartered in Dallas, Texas.